ASPS Predicts New Industry Trends Amidst COVID-19 Re-openings

As the COVID-19 pandemic has changed how plastic surgeons will [...]

By |2020-07-21T00:00:00-05:00July 21, 2020|Industry News, Patient Care, Practice Management|Comments Off on ASPS Predicts New Industry Trends Amidst COVID-19 Re-openings

Chicago Reinstates Targeted COVID-19 Restrictions to Help Combat Recent Rise in Community Cases

Chicago Mayor Lori E. Lightfoot, the Chicago Department of Public [...]

By |2020-07-20T00:00:00-05:00July 20, 2020|Industry News, News|Comments Off on Chicago Reinstates Targeted COVID-19 Restrictions to Help Combat Recent Rise in Community Cases

Doctors and Medical Aesthetics Industry Unite to Fight Food Shortage in Austin, Texas, Amid Pandemic

In the wake of this rapidly changing socio-economic landscape, Dr. [...]

By |2020-07-16T00:00:00-05:00July 16, 2020|Industry News, Patient Care|Comments Off on Doctors and Medical Aesthetics Industry Unite to Fight Food Shortage in Austin, Texas, Amid Pandemic

Governor Orders Businesses to Close Indoor Operations in Most Central California Counties

California Governor Gavin Newsom has ordered gyms, churches and several [...]

By |2020-07-15T00:00:00-05:00July 15, 2020|Industry News, News, State Laws|Comments Off on Governor Orders Businesses to Close Indoor Operations in Most Central California Counties

Restylane Brand Shares First-of-its-kind Phase IV Kissability Study Results

The Restylane brand has announced results of a first-of-its-kind phase [...]

By |2020-07-14T00:00:00-05:00July 14, 2020|Clinical Practice, Industry News, Patient Care|Comments Off on Restylane Brand Shares First-of-its-kind Phase IV Kissability Study Results

ITC Favors Allergan Partner Medytox Over Daewoong in Botulinum Toxin Strain Dispute

The U.S. International Trade Commission (ITC) has sided with South [...]

By |2020-07-10T00:00:00-05:00July 10, 2020|Industry News, News|Comments Off on ITC Favors Allergan Partner Medytox Over Daewoong in Botulinum Toxin Strain Dispute

Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA for Injection

Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic [...]

By |2020-07-09T00:00:00-05:00July 9, 2020|Clinical Practice, Industry News, News|Comments Off on Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA for Injection
Go to Top